Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Source:http://linkedlifedata.com/resource/pubmed/id/17822364

Download in:

View as

General Info

PMID
17822364